Printer Friendly

Fisher Scientific Completes Acquisition of Pharmaceutical Packaging Services Business from Covance Inc.

Fisher Enhances Outsourcing Service Capabilities

HAMPTON, N.H., Feb. 14 /PRNewswire/ --

Fisher Scientific International Inc. (NYSE: FSH), the world leader in serving science, announced today that it has completed the acquisition of the pharmaceutical packaging services business of Covance Inc. (NYSE: CVD) for $137.5 million, and has renamed it Fisher Clinical Services Inc.

(Photo: )

Fisher Clinical Services is a worldwide, leading provider of contract packaging services for clinical trials to major pharmaceutical and biotechnology companies, with cGMP (current Good Manufacturing Practices) manufacturing and packaging facilities in Allentown, Pa.; Basel, Switzerland; and Horsham, U.K.

Fisher Clinical Services enhances the company's current service offerings that include contract formulation and packaging of pharmaceutical, diagnostic and biotech products; custom synthesis for drug discovery; and manufacturing and sourcing of fine, organic and synthetic chemicals. Fisher also is the leading worldwide supplier of virtually all the products, supplies and equipment necessary to operate a research laboratory.

Fisher Scientific International Inc.

As the world leader in serving science, Fisher Scientific ( is the global source of laboratory supplies and equipment, e-commerce procurement technology and related services for research, healthcare, science education and occupational safety. Alchematrix (, a business-to-business e-commerce subsidiary of Fisher Scientific, incorporates all of the capabilities and functionalities of, the world's largest and most comprehensive virtual marketplace for buying scientific supplies.

This announcement includes forward-looking statements. Fisher Scientific has based these forward-looking statements on their current expectations and projections about future events. Although Fisher Scientific believes that its assumptions made in connection with the forward-looking statements are reasonable, no assurances can be given that their assumptions and expectations will prove to have been correct. These forward-looking statements are subject to various risks, uncertainties and assumptions. Fisher Scientific undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. In light of these risks, uncertainties and assumptions, the forward-looking events discussed in this announcement might not occur.

Note to Editors: Today's news release, along with other news about Fisher Scientific is available on the Internet at
COPYRIGHT 2001 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2001 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Geographic Code:1USA
Date:Feb 14, 2001

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters